A nanoparticle drug delivery vehicle for small interfering RNA (ribonucleic acid) molecules (siRNA) shows promise for the treatment of head and neck cancer, according to

LED Medical Diagnostics, makers of the VELscope oral cancer screening device and parent company of LED Dental, reported record revenues for 2011 (end-December 31) and

Gruen von Behrens’s first surgery took 13 hours when he was 17 years old. Two years later, maxillofacial surgeons transplanted bone from his back to

Metformin may protect against oral cancer, according to a new study in Cancer Prevention Research. Metformin is the most widely used treatment for patients with

A naturally occurring, harmless human virus may boost the effects of two standard chemotherapy drugs in some cancer patients, according to new data published in

A chemical present in smokeless tobacco products is a strong oral carcinogen, according to research being presented this week at the American Association for Cancer

In honor of Oral Cancer Awareness Month this month, 340 Aspen Dental practices in 22 states will donate $5 from every ViziLite Plus screening conducted

The U.S. Food and Drug Administration (FDA) has released two separate draft guidance documents to help fight the tobacco epidemic and prevent children from using

Toluidine blue (TBlue) is a useful adjunct to visual examination in the detection of oral cancer, but its sensitivity is low when used to detect

Data from a Phase III clinical trial of 99m-Tc-tilmanocept, also known as Lymphoseek (Navidea Biopharmaceuticals) in oral and squamous cell cancers (SCC) suggest it may

Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in